Publications

10 Most Recent Open Access Publications

Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)

Dick JK, Sangala JA, Krishna VD, Khaimraj A, Hamel L, Erickson SM, Hicks D, Soigner Y, Covill LE, Johnson A, Ehrhardt MJ, Ernste K, Brodin P, Koup RA, Khaitan A, Baehr C, Thielen BK, Henzler CM, Skipper C, Miller JS, Bryceson YT, Wu J, John CC, Panoskaltsis-Mortari A, Orioles A, Steiner ME, Cheeran MC, Pravetoni M, Hart GT.

bioRxiv [Preprint]. 2024 Apr 18:2024.04.16.589585. doi: 10.1101/2024.04.16.589585.

PMID: 38659969

TitleAuthorsCitationPMIDDOI
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)Dick JK, Sangala JA, Krishna VD, Khaimraj A, Hamel L, Erickson SM, Hicks D, Soigner Y, Covill LE, Johnson A, Ehrhardt MJ, Ernste K, Brodin P, Koup RA, Khaitan A, Baehr C, Thielen BK, Henzler CM, Skipper C, Miller JS, Bryceson YT, Wu J, John CC, Panoskaltsis-Mortari A, Orioles A, Steiner ME, Cheeran MC, Pravetoni M, Hart GT.bioRxiv [Preprint]. 2024 Apr 18:2024.04.16.589585. doi: 10.1101/2024.04.16.589585.38659969https://doi.org/10.1101/2024.04.16.589585
The fentanyl-specific antibody FenAb024 can shield against carfentanil effectsUrban K, Gkeka A, Chandra M, Greiner D, Pollich S, Ruf S, Kelemen Y, Sundermann T, Pravetoni M, Baehr C, Stebbins CE, Papavasiliou FN, Verdi JP.Toxicol Lett. 2024 May 15;396:1-10. doi: 10.1016/j.toxlet.2024.03.008. Epub 2024 Apr 6.38588756https://doi.org/10.1016/j.toxlet.2024.03.008
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NPAverick SE, Kassick AJ, Song D, Zhang B, Vigliaturo J, Luengas D, Silva-Ortiz P, Pravetoni M, Raleigh MD.Front Psychiatry. 2024 Mar 14;15:1366186. doi: 10.3389/fpsyt.2024.1366186. eCollection 2024.38550534https://doi.org/10.3389/fpsyt.2024.1366186
Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl ChallengePowers N, Massena C, Crouse B, Smith M, Hicks L, Evans JT, Miller S, Pravetoni M, Burkhart D.Bioconjug Chem. 2023 Oct 18;34(10):1811-1821. doi: 10.1021/acs.bioconjchem.3c00347. Epub 2023 Sep 27.37758302https://doi.org/10.1021/acs.bioconjchem.3c00347
A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine modelsCrouse B, Miller SM, Muelken P, Hicks L, Vigliaturo JR, Marker CL, Guedes AGP, Pentel PR, Evans JT, LeSage MG, Pravetoni M.NPJ Vaccines. 2023 Jul 24;8(1):107. doi: 10.1038/s41541-023-00697-9.37488109https://doi.org/10.1038/s41541-023-00697-9
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in miceMiller SM, Crouse B, Hicks L, Amin H, Cole S, Bazin HG, Burkhart DJ, Pravetoni M, Evans JT.NPJ Vaccines. 2023 Jul 10;8(1):97. doi: 10.1038/s41541-023-00694-y.37429853https://doi.org/10.1038/s41541-023-00694-y
IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in MiceCrouse B, Baehr C, Hicks D, Pravetoni M.J Immunol. 2023 May 1;210(9):1272-1280. doi: 10.4049/jimmunol.2200605.36939374https://doi.org/10.4049/jimmunol.2200605
The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisisMartinez S, Harris H, Chao T, Luba R, Pravetoni M, Comer SD, Jones JD.Expert Opin Investig Drugs. 2023 Mar;32(3):181-185. doi: 10.1080/13543784.2023.2187286. Epub 2023 Mar 6.36863002https://doi.org/10.1080/13543784.2023.2187286
Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanylGallant JP, Hicks D, Shi K, Moeller NH, Hoppe B, Lake EW, Baehr C, Pravetoni M, Aihara H, LeBeau AM.J Biol Chem. 2024 Aug;300(8):107502. doi: 10.1016/j.jbc.2024.107502. Epub 2024 Jun 2838945452https://doi.org/10.1016/j.jbc.2024.107502
ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2Dick JK, Hicks D, Krishna VD, Sangala JA, Zandstra BT, Baehr C, Verbeek JS, Cragg MS, Cheeran MC, Pravetoni M, Hart GT.bioRxiv [Preprint]. 2024 Jun 21:2024.06.20.599956. doi: 10.1101/2024.06.20.599956.38948747https://doi.org/10.1101/2024.06.20.599956

Marco Pravetoni Pubmed Search

Marco Pravetoni Google Scholar